GENASCENCE
Clinical-stage biotechnology company developing life-changing gene therapy products for musculoskeletal diseases
GENASCENCE
Social Links:
Industry:
Biotechnology
Founded:
2017-01-01
Website Url:
http://www.genascence.com
Status:
Active
Total Funding:
10.5 M USD
Similar Organizations
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Global Blood Therapeutics
GBT is a clinical-stage biopharmaceutical company developing a therapy for sickle cell disease.
Theolytics
Theolytics is a pre-clinical stage biotechnology company developing next-generation oncolytic viral therapies.
Current Employees Featured
Founder
Investors List
Pacira Pharmaceuticals
Pacira Pharmaceuticals investment in Series A - Genascence
DeepWork Capital
DeepWork Capital investment in Series A - Genascence
University of Florida Research Foundation
University of Florida Research Foundation investment in Series A - Genascence
Polymerase Capital
Polymerase Capital investment in Series A - Genascence
Official Site Inspections
http://www.genascence.com
- Host name: 116.150.227.35.bc.googleusercontent.com
- IP address: 35.227.150.116
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043

More informations about "Genascence"
Genascence - Crunchbase Company Profile & Funding
Genascence is a clinical-stage biotechnology company that is using gene therapy to revolutionize the treatment of common musculoskeletal diseases. The company intends to tackle one of the โฆSee details»
Genascence Corporation - LinkedIn
Genascence Corporation | 638 followers on LinkedIn. Clinical-stage biotechnology company developing life-changing gene therapy products for musculoskeletal diseases | Revolutionizing treatment for ...See details»
Genascence 2025 Company Profile: Valuation, Funding โฆ
Genascence was founded in 2017. Where is Genascence headquartered? Genascence is headquartered in Palo Alto, CA. What is the size of โฆSee details»
Genascence Corporation Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Genascence Corporation of Palo Alto, CA. Get the latest business insights from Dun & Bradstreet.See details»
Genascence - 2025 Company Profile, Funding & Competitors
Mar 28, 2025 Genascence is a series A company based in Palo Alto (United States), founded in 2017 by Thomas W Chalberg. It operates as a Developer of gene therapies for โฆSee details»
Genascence - Headquarter Location, Corporate Office Address and โฆ
Genascence is Biotechnology in United States that focus on developer business. Founded in 2017. They cover business area such as developer, genetic therapy, treatment, โฆSee details»
Genascence Company Profile - Craft
Genascence has 5 employees at their 1 location. See insights on Genascence including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Team - Genascence
Before joining Genascence, Marianne served as a Senior Director in Clinical Operations at a small biotech company that focused on mast and stem cells diseases. Prior to that, she spent 16 โฆSee details»
Genascence - Contacts, Employees, Board Members, Advisors
Clinical-stage biotechnology company developing life-changing gene therapy products for musculoskeletal diseasesSee details»
Org Chart Genascence - The Official Board
Organizational Chart of Genascence. Genascence genascence.com. has 13 executives +1 707 530 2523; Add an executive. Genascence News . Anything missing? We search for you. Print โฆSee details»
Genascence Corp. - Drug pipelines, Patents, Clinical trials - Synapse
Mar 8, 2025 "Genascence is a company that is transforming how we treat debilitating musculoskeletal diseases like osteoarthritis by pioneering the development of gene therapy," โฆSee details»
Genascence - Overview, News & Similar companies | ZoomInfo.com
Genascence, a clinical-stage biotechnology company revolutionizing the treatment of prevalent musculoskeletal diseases with gene therapy, is develo ping life-changing treatments for highly โฆSee details»
Genascence Receives $11.6 Million Award From California Institute โฆ
PALO ALTO, Calif., Feb. 23, 2023 /PRNewswire/ -- Genascence Corporation ("Genascence"), a clinical-stage biotechnology company revolutionizing the treatment of prevalent โฆSee details»
Genascence - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised ... obfuscated. California Institute for โฆSee details»
Genascence Corporation | Gene Therapies for Musculoskeletal โฆ
Genascence Corporation is a clinical stage life sciences company developing gene therapies for prevalent musculoskeletal and joint diseases. The Companyโs lead candidate (GNSC-001) is a โฆSee details»
Careers - Genascence
A renaissance in gene therapy. We are looking for amazing and passionate individuals to join our mission to develop life-changing therapies for highly prevalent conditions affecting millions of โฆSee details»
Genascence: Pioneering Gene Therapy for Joint Diseases
Genascence, a start-up founded in 2017, aims to break that logjam, transforming the treatment of musculoskeletal (MSK) diseases with single-dose gene therapies. Its technology is based on โฆSee details»
Science - Genascence
In the search to understand, prevent, and treat severe diseases, Genascence is committed to sharing information about clinical trials and making study results publicly accessible. We are โฆSee details»
Our Mission - Genascence
Osteoarthritis (OA) is a degenerative joint disease characterized by destruction of cartilage and structural changes in bone within a joint, such as the knee, which causes pain and disability.See details»
The GenAI Revolution: Balancing Innovation With Responsibility
2 days ago A financial organizationโs failure to live up to that trust could jeopardize an institutionโs relationships with its customers. That's why we view the responsible and ethical โฆSee details»